Alternative sources and metabolic engineering of Taxol: Advances and future perspectives.

Volume: 43, Pages: 107569 - 107569
Published: Nov 1, 2020
Abstract
Paclitaxel is one of the strong plant-derived anti-cancer drugs that was first isolated from the Pacific yew. Despite many paclitaxel's clinical successes, the limited accessibility of paclitaxel for clinical trials is recognized as the most important challenge. Thus, researchers are continuously trying to find the innovative ways to meet the community's need for this medicine. In the first step, the alternative sources for Taxol supply were...
Paper Details
Title
Alternative sources and metabolic engineering of Taxol: Advances and future perspectives.
Published Date
Nov 1, 2020
Volume
43
Pages
107569 - 107569
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.